Trephination versus Minimally Invasive Transnasal Approaches for the Diagnosis and Treatment of Sinus Disease in Horses.

This retrospective case series aims to highlight the advantages and disadvantages of different treatment options for sinus disease in horses, with a special focus on surgical approaches. The medical records of 25 horses with sinusitis which presented to the equine hospital, Vetmeduni Vienna, between August 2020 and January 2022 were analysed. In 11 cases, conservative treatment by the transnasal endoscopic lavage of the affected sinuses through the sinonasal channel or through a developed, pre-existing sinonasal fistula was performed. In the remaining 14 cases, openings into the sinus for subsequent lavage were surgically created either via classical trephination/bone flaps (8) or by transnasal endoscopically guided minimally invasive approaches (8). In some cases (2), a combination of classical extra-nasal and minimally invasive transnasal approaches was required. The minimally invasive techniques used were comprised of laser surgery (3), electrosurgery (3) and balloon sinoplasty (2). The sinusitis and underlying diseases were successfully treated in all of the horses until hospital discharge. Long-term follow-up could be obtained only from a small number of patients due to the temporal proximity (the study began two years ago) to their initial discharge from the hospital, but they showed the continuous resolution of clinical signs in all cases in which follow up data were available. The results of this case series indicate that if surgical intervention is required, minimally invasive techniques appear to be a promising and potentially cheaper alternative to classical extra-nasal approaches for the treatment of sinus disease in selected cases. In the future, the use of these techniques should be considered more commonly with the broader availability of improved endoscopes and instruments. Additionally, by using small-diameter endoscopes, the need for any surgical intervention might be significantly reduced in many cases.

Co-culture of osteochondral explants and synovial membrane as in vitro model for osteoarthritis.

The purpose of the current study was to establish an in vitro model for osteoarthritis (OA) by co-culture of osteochondral and synovial membrane explants. Osteochondral explants were cultured alone (control-1) or in co-culture with synovial membrane explants (control-2) in standard culture medium or with interleukin-1ß (IL1ß) and tumor necrosis factor (TNFα) added to the culture medium (OA-model-1 = osteochondral explant; OA-model-2 = osteochondroal-synovial explant). In addition, in OA-model groups a 2-mm partial-thickness defect was created in the centre of the cartilage explant. Changes in the expression of extracellular matrix (ECM) genes (collagen type-1 (Col1), Col2, Col10 and aggrecan) as well as presence and quantity of inflammatory marker genes (IL6, matrix metalloproteinase-1 (MMP1), MMP3, MMP13, a disintegrin and metalloproteinase with-thrombospondin-motif-5 (ADAMTS5) were analysed by immunohistochemistry, qPCR and ELISA. To monitor the activity of classically-activated pro-inflammatory (M1) versus alternatively-activated anti-inflammatory/repair (M2) synovial macrophages, the nitric oxide/urea ratio in the supernatant of osteochondral-synovial explant co-cultures was determined. In both OA-model groups immunohistochemistry and qPCR showed a significantly increased expression of MMPs and IL6 compared to their respective control group. ELISA results confirmed a statistically significant increase in MMP1and MMP3 production over the culturing period. In the osteochondral-synovial explant co-culture OA-model the nitric oxide/urea ratio was increased compared to the control group, indicating a shift toward M1 synovial macrophages. In summary, chemical damage (TNFα, IL1ß) in combination with a partial-thickness cartilage defect elicits an inflammatory response similar to naturally occurring OA in osteochondral explants with and without osteochondral-synovial explant co-cultures and OA-model-2 showing a closer approximation of OA due to the additional shift of synovial macrophages toward the pro-inflammatory M1 phenotype.

Progressive ossifying paranasal sinus mass of suspected traumatic origin in a mare: Surgical treatment and follow-up.

This report describes a case of a multilobular, osseous mass including parts of the right orbit, concho frontal sinus and right ventral and dorsal conchal sinuses that developed after a traumatic insult to the right maxillary sinus 4 years prior to presentation. Surgical removal of the mass including parts of the bony orbit and long-term outcome are reported.

Masse des sinus paranasaux à ossification progressive d'origine traumatique soupçonnée chez une jument : traitement chirurgical et suivi. Ce rapport décrit une masse multilobulaire et osseuse comprenant des parties de l'orbite droite, des cornets nasaux frontaux et des sinus ventral et dorsal droits qui s'est développée après un traumatisme du sinus maxillaire droit 4 années avant la présentation. L'ablation chirurgicale de la masse, incluant des parties de l'orbite osseuse et les résultats à long terme sont signalés.(Traduit par Isabelle Vallières).

Fetal articular cartilage regeneration versus adult fibrocartilaginous repair: secretome proteomics unravels molecular mechanisms in an ovine model.

Osteoarthritis (OA), a degenerative joint disease characterized by progressive cartilage degeneration, is one of the leading causes of disability worldwide owing to the limited regenerative capacity of adult articular cartilage. Currently, there are no disease-modifying pharmacological or surgical therapies for OA. Fetal mammals, in contrast to adults, are capable of regenerating injured cartilage in the first two trimesters of gestation. A deeper understanding of the properties intrinsic to the response of fetal tissue to injury would allow us to modulate the way in which adult tissue responds to injury. In this study, we employed secretome proteomics to compare fetal and adult protein regulation in response to cartilage injury using an ovine cartilage defect model. The most relevant events comprised proteins associated with the immune response and inflammation, proteins specific for cartilage tissue and cartilage development, and proteins involved in cell growth and proliferation. Alarmins S100A8, S100A9 and S100A12 and coiled-coil domain containing 88A (CCDC88A), which are associated with inflammatory processes, were found to be significantly upregulated following injury in adult, but not in fetal animals. By contrast, cartilage-specific proteins like proteoglycan 4 were upregulated in response to injury only in fetal sheep postinjury. Our results demonstrate the power and relevance of the ovine fetal cartilage regeneration model presented here for the first time. The identification of previously unrecognized modulatory proteins that plausibly affect the healing process holds great promise for potential therapeutic interventions.

Course of serum amyloid A (SAA) plasma concentrations in horses undergoing surgery for injuries penetrating synovial structures, an observational clinical study.

BACKGROUND: Injuries penetrating synovial structures are common in equine practice and often result in septic synovitis. Significantly increased plasma levels of serum amyloid A (SAA) have been found in various infectious conditions in horses including wounds and septic arthritis. Plasma SAA levels were found to decrease rapidly once the infectious stimulus was eliminated. The purpose of the current study was to investigate the usefulness of serial measurements of plasma SAA as a monitoring tool for the response to treatment of horses presented with injuries penetrating synovial structures. In the current study plasma SAA concentrations were measured every 48 hours (h) during the course of treatment. RESULTS: A total of 19 horses with a wound penetrating a synovial structure were included in the current study. Horses in Group 1 (n = 12) (injuries older than 24 h) only needed one surgical intervention. Patients in this group had significantly lower median plasma SAA levels (P = 0.001) between 48 h (median 776 mg/L) and 96 h (median 202 mg/L) after surgery. A significant decrease (P = 0.004) in plasma SAA levels was also observed between 96 h after surgery (median 270 mg/L) and 6 days (d) after surgery (median 3 mg/L). Four horses (Group 2) required more than one surgical intervention. In contrast to Group 1 patients in Group 2 had either very high initial plasma concentrations (3378 mg/L), an increase or persistently high concentrations of plasma SAA after the first surgery (median 2525 mg/L). A small group of patients (n = 3) (Group 3) were admitted less than 24 h after sustaining a wound. In this group low SAA values at admission (median 23 mg/L) and peak concentrations at 48 h after surgery (median 1016 mg/L) were observed followed by a decrease in plasma SAA concentration over time. CONCLUSIONS: A decrease in plasma SAA concentrations between two consecutive time points could be associated with positive response to treatment in the current study. Therefore, serial measurements of plasma SAA could potentially be used as an additional inexpensive, quick and easy tool for monitoring the treatment response in otherwise healthy horses presented with injuries penetrating synovial structures. However further studies will be necessary to ascertain its clinical utility.